ipilimumab,nivolumab,durvalumab,paclitaxel,carboplatin,cisplatin,gemcitabine,docetaxel,pemetrexed
bms,astrazeneca
['durva', 'nsclc', 'nadim 2', 'check,mate,816', 'aegean', 'sclc']
aegean trial with durvalumab confirms improvement of pcr and efs for perioperative chemoimmunotherapy in resectable nsclc with similar impact that checkmate 816 and nadim 2 performed by #aacr23 
Born in Majorca. Medical oncologist. Clinical researcher. Focused in lung cancer. World citizen. Major concerns: human inequality and blue planet environment